The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction

Vascular Pharmacology

Volumn 58, Issue 3, 2013, Pages 182-188

  van Nieuwenhoven, Frans A ^a   Turner, Neil A ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Cardiac fibroblasts; Fibrosis; Heart; Inflammation; Myocardial remodeling

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CXCL1 CHEMOKINE; INTERLEUKIN 1; MATRIX METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AUTOCRINE EFFECT; CARDITIS; CELL MATURATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBROBLAST; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE REVASCULARIZATION; HUMAN; MYOCARDITIS; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; CHEMOKINES; CYTOKINES; FIBROBLASTS; FIBROSIS; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOFIBROBLASTS; NEOVASCULARIZATION, PHYSIOLOGIC; VENTRICULAR REMODELING;

EID: 84874969415     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.07.003     Document Type: Review

References (76)

1. Abraham D.J., Shiwen X., Black C.M., Sa S., Xu Y., Leask A. Tumor necrosis factor α suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J. Biol. Chem. 2000, 275:15220-15225.
2. Abreu J.G., Ketpura N.I., Reversade B., De Robertis E.M. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat. Cell Biol. 2002, 4:599-604.
3. Bond M., Fabunmi R.P., Baker A.H., Newby A.C. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett. 1998, 435:29-34.
4. Bornstein P., Sage E.H. Matricellular proteins: extracellular modulators of cell function. Curr. Opin. Cell Biol. 2002, 14:608-616.
5. Brown R.D., Jones G.M., Laird R.E., Hudson P., Long C.S. Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts. Biochem. Biophys. Res. Commun. 2007, 362:200-205.
6. Bujak M., Frangogiannis N.G. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc. Res. 2007, 74:184-195.
7. Bujak M., Frangogiannis N.G. The role of IL-1 in the pathogenesis of heart disease. Arch. Immunol. Ther. Exp. (Warsz.) 2009, 57:165-176.
8. Burgess M.L., Carver W.E., Terracio L., Wilson S.P., Wilson M.A., Borg T.K. Integrin-mediated collagen gel contraction by cardiac fibroblasts. Effects of angiotensin II. Circ. Res. 1994, 74:291-298.
9. Burns R.J., Gibbons R.J., Yi Q., Roberts R.S., Miller T.D., Schaer G.L., Anderson J.L., Yusuf S. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J. Am. Coll. Cardiol. 2002, 39:30-36.
10. Butt R.P., Laurent G.J., Bishop J.E. Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors. Eur. J. Cell Biol. 1995, 68:330-335.
11. Carlson S., Trial J., Soeller C., Entman M.L. Cardiac mesenchymal stem cells contribute to scar formation after myocardial infarction. Cardiovasc. Res. 2011, 91:99-107.
12. Chen C.J., Kono H., Golenbock D., Reed G., Akira S., Rock K.L. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 2007, 13:851-856.
13. Chua C.C., Chua B.H., Zhao Z.Y., Krebs C., Diglio C., Perrin E. Effect of growth factors on collagen metabolism in cultured human heart fibroblasts. Connect. Tissue Res. 1991, 26:271-281.
14. Chuva de Sousa Lopes S.M., Feijen A., Korving J., Korchynskyi O., Larsson J., Karlsson S., ten D.P., Lyons K.M., Goldschmeding R., Doevendans P., Mummery C.L. Connective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarction. Dev. Dyn. 2004, 231:542-550.
15. Daniels A., van Bilsen M., Goldschmeding R., van der Vusse G.J., van Nieuwenhoven F.A. Connective tissue growth factor and cardiac fibrosis. Acta Physiol. (Oxf.) 2009, 195:321-338.
16. Daskalopoulos E.P., Janssen B.J., Blankesteijn W.M. Myofibroblasts in the infarct area: concepts and challenges. Microsc. Microanal. 2012, 18:35-49.
17. Dewald O., Ren G., Duerr G.D., Zoerlein M., Klemm C., Gersch C., Tincey S., Michael L.H., Entman M.L., Frangogiannis N.G. Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am. J. Pathol. 2004, 164:665-677.
18. Dobaczewski M., Chen W., Frangogiannis N.G. Transforming growth factor (TGF)-β signaling in cardiac remodeling. J. Mol. Cell. Cardiol. 2011, 51:600-606.
19. Drobic V., Cunnington R.H., Bedosky K.M., Raizman J.E., Elimban V.V., Rattan S.G., Dixon I.M. Differential and combined effects of cardiotrophin-1 and TGF-β1 on cardiac myofibroblast proliferation and contraction. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1053-H1064.
20. Eghbali M., Tomek R., Sukhatme V.P., Woods C., Bhambi B. Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ. Res. 1991, 69:483-490.
21. Fix C., Bingham K., Carver W. Effects of interleukin-18 on cardiac fibroblast function and gene expression. Cytokine 2011, 53:19-28.
22. Frangogiannis N.G. Matricellular proteins in cardiac adaptation and disease. Physiol. Rev. 2012, 92:635-688.
23. Frangogiannis N.G., Entman M.L. Chemokines in myocardial ischemia. Trends Cardiovasc. Med. 2005, 15:163-169.
24. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc. Res. 2002, 53:31-47.
25. Frantz S., Hu K., Adamek A., Wolf J., Sallam A., Maier S.K., Lonning S., Ling H., Ertl G., Bauersachs J. Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction. Basic Res. Cardiol. 2008, 103:485-492.
26. Gordon J.R., Galli S.J. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990, 346:274-276.
27. Haudek S.B., Xia Y., Huebener P., Lee J.M., Carlson S., Crawford J.R., Pilling D., Gomer R.H., Trial J., Frangogiannis N.G., Entman M.L. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:18284-18289.
28. Ieda M., Fu J.D., Delgado-Olguin P., Vedantham V., Hayashi Y., Bruneau B.G., Srivastava D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142:375-386.
29. Jayawardena T.M., Egemnazarov B., Finch E.A., Zhang L., Payne J.A., Pandya K., Zhang Z., Rosenberg P., Mirotsou M., Dzau V.J. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ. Res. 2012, 110:1465-1473.
30. Jourdan-Lesaux C., Zhang J., Lindsey M.L. Extracellular matrix roles during cardiac repair. Life Sci. 2010, 87:391-400.
31. Kaur H., Chaurasia S.S., Agrawal V., Suto C., Wilson S.E. Corneal myofibroblast viability: opposing effects of IL-1 and TGF beta1. Exp. Eye Res. 2009, 89:152-158.
32. Keeley E.C., Mehrad B., Strieter R.M. Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int. J. Biochem. Cell Biol. 2010, 42:535-542.
33. Laeremans H., Rensen S.S., Ottenheijm H.C., Smits J.F., Blankesteijn W.M. Wnt/frizzled signalling modulates the migration and differentiation of immortalized cardiac fibroblasts. Cardiovasc. Res. 2010, 87:514-523.
34. Lafontant P.J., Burns A.R., Donnachie E., Haudek S.B., Smith C.W., Entman M.L. Oncostatin M differentially regulates CXC chemokines in mouse cardiac fibroblasts. Am. J. Physiol. Cell Physiol. 2006, 291:C18-C26.
35. Leask A. TGFβ, cardiac fibroblasts, and the fibrotic response. Cardiovasc. Res. 2007, 74:207-212.
36. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ. Res. 2010, 106:1675-1680.
37. 1. Mol. Genet. Metab. 2000, 71:418-435.
38. Lijnen P., Petrov V., Fagard R. Transforming growth factor-beta 1-mediated collagen gel contraction by cardiac fibroblasts. J. Renin Angiotensin Aldosterone Syst. 2003, 4:113-118.
39. Lindsey M.L., Zamilpa R. Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction. Cardiovasc. Ther. 2012, 30:31-41.
40. Liu X., Kelm R.J., Strauch A.R. Transforming growth factor beta1-mediated activation of the smooth muscle alpha-actin gene in human pulmonary myofibroblasts is inhibited by tumor necrosis factor-alpha via mitogen-activated protein kinase kinase 1-dependent induction of the Egr-1 transcriptional repressor. Mol. Biol. Cell 2009, 20:2174-2185.
41. Lucas J.A., Zhang Y., Li P., Gong K., Miller A.P., Hassan E., Hage F., Xing D., Wells B., Oparil S., Chen Y.F. Inhibition of transforming growth factor-beta signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heart. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H424-H432.
42. Manabe I., Shindo T., Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ. Res. 2002, 91:1103-1113.
43. Mitchell M.D., Laird R.E., Brown R.D., Long C.S. IL-1β stimulates rat cardiac fibroblast migration via MAP kinase pathways. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H1139-H1147.
44. Mughal R.S., Warburton P., O'Regan D.J., Ball S.G., Turner N.A., Porter K.E. Peroxisome proliferator-activated receptor γ-independent effects of thiazolidinediones on human cardiac myofibroblast function. Clin. Exp. Pharmacol. Physiol. 2009, 36:478-486.
45. Nakajima H., Nakajima H.O., Salcher O., Dittie A.S., Dembowsky K., Jing S., Field L.J. Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart. Circ. Res. 2000, 86:571-579.
46. Naugle J.E., Olson E.R., Zhang X., Mase S.E., Pilati C.F., Maron M.B., Folkesson H.G., Horne W.I., Doane K.J., Meszaros J.G. Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H323-H330.
47. Nicoletti A., Michel J.B. Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors. Cardiovasc. Res. 1999, 41:532-543.
48. Nowinski D., Hoijer P., Engstrand T., Rubin K., Gerdin B., Ivarsson M. Keratinocytes inhibit expression of connective tissue growth factor in fibroblasts in vitro by an interleukin-1α-dependent mechanism. J. Invest. Dermatol. 2002, 119:449-455.
49. Ono K., Matsumori A., Shioi T., Furukawa Y., Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 1998, 98:149-156.
50. Palatinus J.A., Rhett J.M., Gourdie R.G. Translational lessons from scarless healing of cutaneous wounds and regenerative repair of the myocardium. J. Mol. Cell. Cardiol. 2010, 48:550-557.
51. Palmer J.N., Hartogensis W.E., Patten M., Fortuin F.D., Long C.S. Interleukin-1β induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J. Clin. Invest. 1995, 95:2555-2564.
52. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 2009, 123:255-278.
53. Qian L., Huang Y., Spencer C.I., Foley A., Vedantham V., Liu L., Conway S.J., Fu J.D., Srivastava D. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485:593-598.
54. Rosenkranz S. TGF-β1 and angiotensin networking in cardiac remodeling. Cardiovasc. Res. 2004, 63:423-432.
55. Santiago J.J., Dangerfield A.L., Rattan S.G., Bathe K.L., Cunnington R.H., Raizman J.E., Bedosky K.M., Freed D.H., Kardami E., Dixon I.M. Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts. Dev. Dyn. 2010, 239:1573-1584.
56. Shephard P., Martin G., Smola-Hess S., Brunner G., Krieg T., Smola H. Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. Am. J. Pathol. 2004, 164:2055-2066.
57. Siwik D.A., Colucci W.S. Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail. Rev. 2004, 9:43-51.
58. Siwik D.A., Chang D.L., Colucci W.S. Interleukin-1β and tumor necrosis factor-α decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ. Res. 2000, 86:1259-1265.
59. Song K., Nam Y.J., Luo X., Qi X., Tan W., Huang G.N., Acharya A., Smith C.L., Tallquist M.D., Neilson E.G., Hill J.A., Bassel-Duby R., Olson E.N. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012, 485:599-604.
60. Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol. Rev. 2007, 87:1285-1342.
61. Sun Y., Zhang J.Q., Zhang J., Ramires F.J. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart. J. Mol. Cell. Cardiol. 1998, 30:1559-1569.
62. Swaney J.S., Roth D.M., Olson E.R., Naugle J.E., Meszaros J.G., Insel P.A. Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:437-442.
63. Teekakirikul P., Eminaga S., Toka O., Alcalai R., Wang L., Wakimoto H., Nayor M., Konno T., Gorham J.M., Wolf C.M., Kim J.B., Schmitt J.P., Molkentin J.D., Norris R.A., Tager A.M., Hoffman S.R., Markwald R.R., Seidman C.E., Seidman J.G. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-beta. J. Clin. Invest. 2010, 120:3520-3529.
64. Teunissen B.E., Smeets P.J., Willemsen P.H., De Windt L.J., van Der Vusse G.J., Van Bilsen M. Activation of PPARδ inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts. Cardiovasc. Res. 2007, 75:519-529.
65. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 2002, 3:349-363.
66. Turner N.A., Porter K.E. Regulation of myocardial matrix metalloproteinase expression and activity by cardiac fibroblasts. IUBMB Life 2012, 64:143-150.
67. Turner N.A., Das A., Warburton P., O'Regan D.J., Ball S.G., Porter K.E. Interleukin-1α stimulates pro-inflammatory cytokine expression in human cardiac myofibroblasts. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1117-H1127.
68. Turner N.A., Warburton P., O'Regan D.J., Ball S.G., Porter K.E. Modulatory effect of interleukin-1α on expression of structural matrix proteins, MMPs and TIMPs in human cardiac myofibroblasts: role of p38 MAP kinase. Matrix Biol. 2010, 29:613-620.
69. Turner N.A., Das A., O'Regan D.J., Ball S.G., Porter K.E. Human cardiac fibroblasts express ICAM-1, E-selectin and CXC chemokines in response to proinflammatory cytokine stimulation. Int. J. Biochem. Cell Biol. 2011, 43:1450-1458.
70. Valente A.J., Yoshida T., Gardner J.D., Somanna N., Delafontaine P., Chandrasekar B. Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1. Cell. Signal. 2012, 24:560-568.
71. van den Borne S.W., Diez J., Blankesteijn W.M., Verjans J., Hofstra L., Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat. Rev. Cardiol. 2010, 7:30-37.
72. Verheule S., Sato T., Everett T., Engle S.K., Otten D., Rubart-von der L.M., Nakajima H.O., Nakajima H., Field L.J., Olgin J.E. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-β1. Circ. Res. 2004, 94:1458-1465.
73. Xiao H., Ji A.M., Li Z.L., Song X.D., Su D., Chen A.H. Interleukin-1β inhibits collagen synthesis and promotes its decomposition in cultured cardiac fibroblasts. Sheng Li Xue Bao 2008, 60:355-361.
74. Yu F., Chou C.W., Chen C.C. TNF-α suppressed TGF-β-induced CTGF expression by switching the binding preference of p300 from Smad4 to p65. Cell. Signal. 2009, 21:867-872.
75. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A.L., McMullen J.R., Gustafsson E., Chandraker A., Yuan X., Pu W.T., Roberts A.B., Neilson E.G., Sayegh M.H., Izumo S., Kalluri R. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 2007, 13:952-961.
76. Zhu J., Carver W. Effects of interleukin-33 on cardiac fibroblast gene expression and activity. Cytokine 2012, 58:368-379.